Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

106.88 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Revolutionizing Tech: 7 Growth Stocks to Grab for Dynamic Returns
For investors that want to position themselves for the future, these compelling top growth stocks to buy could be enticing. 
Via InvestorPlace
IRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst Applaud
Truist Securities analyst Richard Newitter reiterated a Buy rating on IRhythm Technologies, Inc. (NASDAQ: IRTC), 
Via Benzinga
Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable
iRhythm Technologies Inc's (NASDAQ: IRTC) revenue of $124.1 million increased 21.6% Y/Y, beating the consensus of $120.3 
Via Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
What 11 Analyst Ratings Have To Say About iRhythm Technologies
Via Benzinga
Citigroup Maintains Neutral Rating for iRhythm Technologies: Here's What You Need To Know
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
iRhythm Technologies' Market-Leading ZioService to Dominate ACM Sector: Analyst Initiates with Outperform Rating
Baird initiated coverage on iRhythm Technologies Inc (NASDAQ: IRTC) with an Outperform rating and  
Via Benzinga
Analyst Expectations for iRhythm Technologies's Future
Via Benzinga
What 9 Analyst Ratings Have To Say About iRhythm Technologies
Via Benzinga
iRhythm Technologies: Q1 Earnings Insights
Via Benzinga
Expert Ratings for iRhythm Technologies
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Robotics Stocks to Target for Triple-Digit Returns in 2023
Harness the power of robotics innovation for your portfolio and invest in these robotics stocks for high returns. 
Via InvestorPlace
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular? 
Via News Direct
Exposures Product Safety
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include viol 
Via Benzinga
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into iRhythm Technologies, Inc. (IRTC)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Top 5 Health Care Stocks That Are Set To Fly In Q2
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
The 3 Most Promising Robotics Stocks to Buy in May 2023
These robotics stocks to buy offer spectacular long-term upside in line with the growth expected in the multi-billion dollar robotics sphere. 
Via InvestorPlace
The 3 Best MedTech Stocks to Watch in May 2023
Here's a look at the best MedTech stocks to watch in May, which include Teladoc, Veeva and iRhythms Technology. 
Via InvestorPlace
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
The 7 Most Innovative Stocks to Invest in Today
These innovative stocks are back trading in the green, offering tremendous upside ahead in sustained bull-run ahead. 
Via InvestorPlace
3 Thrilling Robotics Stocks for Aggressive Investors to Buy
These robotics stocks to buy offer incredible upside potential in a sector poised for rapid long-term adoption. 
Via InvestorPlace
The 7 Best Robotics Stocks to Buy for Long-Term Growth
These best robotics stocks are risky bets at this time but are poised to dominate the massive mechatronics market. 
Via InvestorPlace
10 Companies That Had Tons of Money in SVB When It Collapsed
Silicon Valley Bank is gone but its clients are still here. Many prominent companies, and not just startups, had money in SVB. 
Via InvestorPlace
4 Stocks With Huge Cash Holdings at Silicon Valley Bank
How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day? 
Via MarketBeat
Topics ETFs Economy
Exposures Interest Rates
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.